| Literature DB >> 12093728 |
Pascal Béguin1, Gilles Crambert, Florianne Monnet-Tschudi, Marc Uldry, Jean-Daniel Horisberger, Haim Garty, Käthi Geering.
Abstract
Recently, corticosteroid hormone-induced factor (CHIF) and the gamma-subunit, two members of the FXYD family of small proteins, have been identified as regulators of renal Na,K-ATPase. In this study, we have investigated the tissue distribution and the structural and functional properties of FXYD7, another family member which has not yet been characterized. Expressed exclusively in the brain, FXYD7 is a type I membrane protein bearing N-terminal, post-translationally added modifications on threonine residues, most probably O-glycosylations that are important for protein stabilization. Expressed in Xenopus oocytes, FXYD7 can interact with Na,K-ATPase alpha 1-beta 1, alpha 2-beta 1 and alpha 3-beta 1 but not with alpha-beta 2 isozymes, whereas, in brain, it is only associated with alpha 1-beta isozymes. FXYD7 decreases the apparent K(+) affinity of alpha 1-beta 1 and alpha 2-beta 1, but not of alpha 3-beta1 isozymes. These data suggest that FXYD7 is a novel, tissue- and isoform-specific Na,K-ATPase regulator which could play an important role in neuronal excitability.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12093728 PMCID: PMC125393 DOI: 10.1093/emboj/cdf330
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598